The 37 references in paper V. Polovinkina S., E. Markov Yu., В. Половинкина С., Е. Марков Ю. (2014) “СТРУКТУРА И ИММУНОАДЪЮВАНТНЫЕ СВОЙСТВА CPG-ДНК // STRUCTURE AND IMMUNE ADJUVANT PROPERTIES OF CPG-D” / spz:neicon:mimmun:y:2010:i:6:p:469-476

1
Козлов И.Г., Тимаков М.А. Иммунотерапия: вчера, сегодня, завтра // Педиатрия. –
(check this in PDF content)
2
09. – Т. 87, No 4. – С. 140-149. 2. Марков Е.Ю., Николаев В.Б., Загоскина Т.Ю., Половинкина В.С., Иванова Т.А., Саппо С.Г., Андреевская Н.М., Михайлова В.А., Голубинский Е.П. Протективная активность субклеточных фракций Yersinia pestis при экспериментальной чуме у белых мышей // Бюллетень ВСНЦ СО РАМН. – 2004. – Т. 2, No 1. – С. 123-127.
(check this in PDF content)
3
Олишевский С.В., Козак В.В., Мазур О.В., Шляховенко В.А. Применение CpG ДНК Bacillus subtilis в экспериментальной иммунотерапии опухолей // Российский биотерапевтический журнал. – 2007. – Т. 6, No 3. – С. 19-29.
(check this in PDF content)
4
Половинкина В.С., Иванова Т.А., Николаев В.Б., Марков Е.Ю. Получение микрокорпускулярного антигенного комплекса, способного формировать напряженный иммунитет против чумы на фоне экстренной неспецифической профилактики // Журнал инфекционной патологии. – 2009. – Т. 16, No 3. – С. 178-179.
(check this in PDF content)
5
Рыкова Е.Ю., Лактионов П.П., Власов В.В. Активирующее влияние ДНК на иммунную систему // Успехи современной биологии. – 2001. – Т. 121, No 2. – С. 160-171.
(check this in PDF content)
6
Серебряная Н.Б., Новик А.А. ДНК как иммуностимулятор // Медицинская иммунология. – 2001. – Т. 3, No 1. – С. 27-34.
(check this in PDF content)
7
Akira S., Hoshino K. Myeloid differentiation factor 88-dependent and -independent pathways in toll-like receptor signaling // J. Infect. Dis. – 2003. – Vol. 187, N 2. – P. 356-363.
(check this in PDF content)
8
Amemiya K., Meyers J.L., Rogers T.E., Fast R.L., Bassett A.D., Worsham P.L., Powell B.S., Norris S.L., Krieg A.M., Adamovicz J.J. CpG oligodeoxynucleotides augment the murine immune response to the Yersinia pestis F1-V vaccine in bubonic and pneumonic models of plague // Vaccine. – 2009. – Vol. 27, N 16. – P. 2220-2229.
(check this in PDF content)
9
Barton G. M., Kagan J. C. A cell biological view of Toll-like receptor function: regulation through compartmentalization // Nature Reviews. Immunology. – 2009. – Vol. 9. – P. 535-542.
(check this in PDF content)
10
Beutler B.A. TLRs and innate immunity // Blood. – 2009. – Vol. 113. – P. 1399-1407.
(check this in PDF content)
11
Branda R.F., Moore A.L., Mathews L., McCormack J.J., Zon G. Immune stimulation by an antisense oligomer complementary to the rev gene of HIV-1 // Biochem. Pharmacol. – 1993. – Vol. 45, N 10. – P. 2037-2043.
(check this in PDF content)
12
Chuang T., Ulevitch R.J. Cloning and characterization of a sub-family of human tolllike receptors: hTLR7, hTLR8 and hTLR9 // Eur. Cytokine Netw. – 2000. – Vol. 11. – P. 372-378.
(check this in PDF content)
13
Cooper C.L., Davis H.L., Angel J.B., Morris M.L., Elfer S.M., Seguin I., Krieg A.M., Cameron D.W. CPG 7909 adjuvant improves hepatitis B virus vaccine seroprotection in antiretroviraltreated HIV-infected adults // AIDS. – 2005. – Vol. 19, N 14. – P. 1473-1479.
(check this in PDF content)
14
Francesco R., Migliaccio G. Challenges and successes in developing new therapies for hepatitis C // Nature. – 2005. – Vol. 436, N 18. – P. 953-960.
(check this in PDF content)
15
Elkins K.L., Rhinehart-Jones T.R., Stibitz S., Conover J.S., Klinman D.M. Bacterial DNA containing CpG motifs stimulates lymphocytedependent protection of mice against lethal infection with intracellular bacteria // J. Immunol. – 1999. – Vol. 162, N 4. – P. 2291-2298.
(check this in PDF content)
16
Heit A., Schmitz F., O’Keeffe M., Staib C., Busch D.H., Wagner H., Huster K.M. Protective CD8 T cell immunity triggered by CpG-protein conjugates competes with the efficacy of live vaccines // J. Immunol. – 2005. – Vol. 174, N 7. – P. 4373-4380.
(check this in PDF content)
17
Jin M.S., Lee J.O. Structures of the Tolllike receptor family and its ligand complexes // Immunity. – 2008. – Vol. 29. – P. 182-191.
(check this in PDF content)
18
Jurk M., Vollmer J. Therapeutic applications of synthetic CpG oligodeoxynucleotides as TLR9 agonists for immune modulation // BioDrugs. – 2007. – Vol. 21, N 6. – P. 387-401.
(check this in PDF content)
19
Kaushik P., Singh D.K., Kumar S.V., Tiwari A.K., Shukla G., Dayal S., Chaudhuri P. Protection of mice against Brucella abortus 544 challenge by vaccination with recombinant OMP28 adjuvanted with CpG oligonucleotides // Vet. Res. Commun. – 2010. – Vol. 34, N 2. – P. 119-132.
(check this in PDF content)
20
Kawai T., Akira S. The roles of TLRs, RLRs and NLRs in pathogen recognition // Int. Immunol. – 2009. – Vol. 21, N 4. – P. 317-337.
(check this in PDF content)
21
Kumar H., Kawai T., Akira S. Toll-like receptors and innate immunity // Biochemical and Biophysical Research Communications. – 2009. – Vol. 388. – P. 621-625.
(check this in PDF content)
22
Markov E.Yu., Nikolaev V.B., Ivanova T.A., Golubinsky E.P., Innokenteva T.I., Dubrovina V.I., Polovinkina V.S., Popova Yu.O., Vitjazeva O.I., Kozlov S.N. Protective activity of Yersinia pestis EV antigenic complex with the immunostimulators and combined use of doxycyclin // Scientific Journal of Center for Infectious Diseases with Natural Foci. – 2005. – P. 176-184.
(check this in PDF content)
23
Matsumoto S., Matsumoto M., Umemori K., Ozeki Y., Furugen M., Tatsuo T., Hirayama Y., Yamamoto S., Yamada T., Kobayashi K. DNA augments antigenicity of mycobacterial DNAbinding protein 1 and confers protection against Mycobacterium tuberculosis infection in mice // J. Immunol. – 2005. – Vol. 175, N 1. – P. 441-449.
(check this in PDF content)
24
Medvedev A.E., Lentschat A., Kuhns D.B. Distinct mutations in IRAK-4 confer hyporesponsiveness to lipopolysaccharide and interleukin-1 in a patient with recurrent bacterial infections // J. Exp. Med. – 2003. – Vol. 798. – P. 521-531.
(check this in PDF content)
25
Medzhitov R. Recognition of microorganisms and activation of the immune response // Nature. – 2007. – Vol. 449. – P. 819-826.
(check this in PDF content)
26
Medzhitov R., Preston-Hurlburt P., Janeway C.A. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity // Nature. – 1997. – Vol. 333. – P. 394-397.
(check this in PDF content)
27
O’Neill L.A., Bryant C.E., Doyle S.L. Therapeutic targeting of Toll-like receptors for infectious and inflammatory diseases and cancer // Pharmacol. Rev. – 2009. – Vol. 61, N 2. – P. 177-197.
(check this in PDF content)
28
Pisetsky D.S., Reich C.F. The influence of base sequence on the immunological properties of defined oligonucleotides // Immunopharmacology. – 1998. – Vol. 40, N 3. – P. 199-208.
(check this in PDF content)
29
Ringwood L., Li L. The involvement of the interleukin-1 receptor-associated kinases (IRAKs) in cellular signaling networks controlling inflammation // Cytokine. – 2008. – Vol. 42, N 1. – P. 1-7.
(check this in PDF content)
30
Samulowitz U., Weber M., Weeratna R., Uhlmann E., Noll B., Krieg A.M., Vollmer J.A. Novel Class of Immune-Stimulatory CpG Oligodeoxynucleotides Unifies High Potency in Type I Interferon Induction with Preferred Structural Properties // Oligonucleotides. – 2010. – Vol. 20, N 2. – P. 93-101.
(check this in PDF content)
31
Taghavi A., Allan B., Mutwiri G., Foldvari M., Van Kessel A., Willson P., Babiuk L., Potter A., Gomis S. Enhancement of immunoprotective effect of CpG-ODN by formulation with polyphosphazenes against E. coli septicemia in neonatal chickens // Curr. Drug Deliv. – 2009. – Vol. 6, N 1. – P. 76-82.
(check this in PDF content)
32
Tokunaga T., Yamamoto S., Namba K. A synthetic single-stranded DNA, poly (dG,dC), induces interferon-′/′and -′, augments natural killer activity, and suppresses tumor growth // Jpn. J. Cancer Res. – 1988. – Vol. 79, N 6. – P. 682-686.
(check this in PDF content)
33
Uddowla S., Freytag L.C., Clements J.D. Effect of adjuvants and route of immunizations on the immune response to recombinant plague antigens // Vaccine. – 2007. – Vol. 25, N 47. – P. 7984-7993.
(check this in PDF content)
34
Maren W.W., Jacobs J.F., de Vries I.J., Nierkens S., Adema G.J. Toll-like receptor signalling on Tregs: to suppress or not to suppress? // Immunology. – 2008. – Vol. 124, N 4. – P. 445-452.
(check this in PDF content)
35
Vollmer J., Krieg A.M. Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists // Advanced Drug Delivery Reviews. – 2009. – Vol. 61. – P. 195-204.
(check this in PDF content)
36
Yamamoto S., Yamamoto T., Shimada S., Kuramoto E., Yano O, Kataoka T., Tokunaga T. DNA from bacteria, but not from vertebrates, induces interferons, activates natural killer cells and inhibits tumor growth // Microbiol. Immunol. – 1992. – Vol. 36, N 9. – P. 983-997.
(check this in PDF content)
37
Yu P. Nucleic acid recognizing Tolllike receptors as therapeutic targets: a focus on autoimmunity and cancer // Journal of Receptor, Ligand and Channel Research. – 2009. – Vol. 2. – P. 19-28.
(check this in PDF content)